(Q38506829)

3 September 2017

1 reference

title

Safety and effectiveness of MF-59 adjuvanted influenza vaccines in children and adults (English)

1 reference

3 September 2017

1 reference

Steven Black

1

1 reference

PubMed ID

26022564

3 September 2017

language of work or name

English

0 references

publication date

1 June 2015

1 reference

3 September 2017

1 reference

3 September 2017

33 Suppl 2

1 reference

3 September 2017

B3-5

1 reference

Adjuvants for human vaccines--current status, problems and future prospects

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.062

Oil-in-water emulsion adjuvant with influenza vaccine in young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.062

The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.062

7 January 2021

Safety of MF59 adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.062

Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.062

Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.062

Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.062

Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.062

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.062

MF59 adjuvant: the best insurance against influenza strain diversity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.062

Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.062

10.1016/J.VACCINE.2014.11.062

7 January 2021

Identifiers

DOI

1 reference

3 September 2017

1 reference

PubMed ID

26022564